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ABSTRAK
Latar belakang: infeksi HIV pada kehamilan merupakan masalah besar untuk masa depan bangsa. Virus 
ini dapat ditularkan ke bayi melalui kehamilan, persalinan dan selama menyusui yang memerlukan deteksi dan 
intervensi dini. Tujuan dari penelitian ini adalah untuk menggambarkan proses pencegahan penularan di antara 
pasien kami. Metode: ini adalah studi kohort retrospektif penularan vertikal HIV. Kriteria inklusi adalah wanita 
hamil dengan infeksi HIV yang menjalani perawatan antenatal di Rumah Sakit Cipto Mangunkusumo dari Januari 
2013 hingga Desember 2018. Data diambil dari rekam medis, registrasi HIV dan hasil laboratorium. Data yang 
dimasukkan adalah demografi, risiko infeksi, data obstetri, cara persalinan, riwayat ARV, riwayat laboratorium 
pada ibu dan bayi. Data disajikan sebagai data deskriptif. Hasil: terdapat 138 wanita hamil HIV dimasukkan 
sebagai subyek penelitian. Sebagian besar wanita berusia 25-29 tahun (39,85%), sebagai ibu rumah tangga 
(41,30%), dengan riwayat lebih dari satu pasangan seksual (50,73%). Subjek sebagian besar multigravida (77,5%), 
kunjungan pertama ke RSCM pada trimester ketiga (98,6%), dengan riwayat perawatan antenatal >4 kali (48,6%), 
janin tunggal (99,3%), dan disampaikan oleh C-section (84,1%) . Diagnosis HIV dilakukan selama kehamilan 
(73,53%), dan sudah memakai antiretroviral (ARV) selama lebih dari 6 bulan (50,7%). Didapatkan data CD4 pada 
78% peserta (24% peserta dengan <200 sel/mL) dan 84% data viral load (36% dengan viral load >200). Sekitar 
72,5% bayi yang lahir dengan berat lahir 2500-3500g. Hampir semua bayi menerima profilaksis ARV (97,9%) 
dan pemberian susu formula. PCR HIV diperiksa pada 16 bayi pada usia 6 minggu dan pada13 bayi di usia 6 
bulan. Ada 1 bayi dengan hasil viral load >400 yang segera merujuk ke klinik HIV Pediatrik. Analisis bivariat 
menunjukkan korelasi yang signifikan antara konsumsi ARV ibu dan hasil bayi saat lahir (P=0,05). Tingkat CD4 
ibu tidak berkorelasi secara signifikan dengan status virologi neonatal (P=0,12). Kesimpulan: diagnosis HIV 
pada wanita hamil adalah penting, karena pemberian ARV pada awal kehamilan secara signifikan mengurangi 
penularan vertikal. Protokol profilaksis ARV penting untuk mencegah infeksi HIV pada bayi.
Kata kunci: HIV dalam kehamilan, luaran obstetrik, luaran bayi.
ABSTRACT
Background: HIV infection in pregnancy is a big concern for the future of our nation. The virus can be 
transmitted to the baby through pregnancy, childbirth and during breastfeeding which rendering to early detection and 
intervention. The aim of this study was to describe the transmission prevention cascade among our patient. Methods: 
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INTRODUCTION
Human Immunodeficiency Virus (HIV)/ 
Acquired Immune Deficiency Syndrome (AIDS) 
is one of the world’s growing and increasing 
health problems. As many as 36.7 million people 
live with HIV with 1.5 million deaths due to 
AIDS based on data until the end of 2015.1 The 
incidence pregnant women with HIV in Asia was 
around 77,000 in the end of 2015.2 In Indonesia, 
the total number of pregnant women living with 
HIV was 2955 in 2018.
HIV infection in pregnancy has become 
the most common problem in some developing 
countries. It has major implication for the 
management of pregnancy and birth.3,4 The 
program to prevent transmission of HIV infection 
from mother to child (PMTCT) in Indonesia has 
included HIV screening as one of the standard 
examinations during antenatal care which widely 
applied in the last 5 year.5 There were more than 
15 million pregnant women with HIV infection 
in developing countries and more than 500,000 
infected babies born HIV every year. Based 
on previous studies, it was found that 2.5% of 
21,103 pregnant women diagnosed with HIV 
positive in 2011 in Indonesia.6 Interventions to 
prevent HIV transmission from mother to infant 
are needed so as not to increase the number of 
HIV-infected children. Possible interventions 
are achieveable by preventing HIV infection in 
women-child-bearing age, managing pregnant 
women with HIV infection with antiretroviral 
(ARV) to achieve reduction of viral load, 
minimizing fetal exposure to blood and body 
fluids during delivery, and optimizing the health 
of neonates born to mothers with HIV infection. 
This study is about pregnant women with HIV 
infection and the outcomes on infants in tertiary 
referral hospital.
METHODS
This was a restrospective cohort study. 
The population of the study were all pregnant 
and in labor women with HIV infection at 
RSUPN Cipto Mangunkusumo Jakarta from 
January 2013 up to December 2018. The 
inclusion criteria was pregnant women with HIV 
infection who have antenatal care, delivery and 
follow up in Cipto Mangunkusumo Hospital. 
Total sampling was used. This study has been 
approved by the Ethical Committee of Faculty 
of Medicine Universitas Indonesia (reference 
number: 0035/UN2.F1/ETIK/2019).
Typically patients referred to our hospital 
due to their obstetric problem and/or their HIV 
status. The obstetric care coordinated with 
HIV integrated service especially for HIV and 
comorbidity and ARV treatment. Once the 
this was a retrospective cohort study of HIV vertical transmission. The inclusion criteria was pregnant women with 
HIV infection who have antenatal care in Cipto Mangunkusumo Hospital from January 2013 up to December 2018. 
Data was retrieved from medical record, HIV registry and laboratory results. The included data were demographic, 
risk of infection, obstetrical data, mode of delivery, ARV history, laboratory history in mother and infant. Data was 
presented as descriptive. Results: there was 138 HIV pregnant women included as study subjects. Most women were 
at 25-29 years old (39.85%), as housewife (41.30%), with history of more than one sexual partners (50.73%). The 
subjects was mostly multigravida (77.5%), first visit to RSCM in third trimester (98.6%), with history of antenatal 
care >4 times (48.6%), singleton fetus (99.3%), and delivered by C-section (84.1%). HIV diagnosis was done during 
pregnancy (73.53%), and already on antiretroviral (ARV) for more than 6 months (50.7%). There was 78% subjects 
with CD4 (24% subjects with <200 cells/mL) and 84% with viral load data (36% with viral load >200 copies/uL). 
Around 72.5% infants born with birth weight 2500-3500g. Almost all infant received ARV prophylaxis (97.9%) and 
formula feeding. PCR HIV was examined on 16 infant on 6 weeks of age and and 13 on 6 month age. There was 1 
infant with viral load results >400 copies/ml which immediately refered to Pediatric HIV clinic. Bivariate analysis 
showed significant correlation between maternal ARV consumption and infant result at birth (P=0.05). Maternal CD4 
level was not significantly correlate with neonatal virology status (P=0.12). Conclusion: HIV diagnosis in pregnant 
women is important, since ARV administration on early pregnancy significantly reduce vertical transmission. ARV 
prophylaxis protocols is important to prevent HIV infection on infant.
Keywords: HIV in pregnancy, obstetric outcome, infant outcome.
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Table 1. Distribution of maternal characteristics (2013-
2018) (N=138).
Characteristic of Subjects n (%)
Age of subjects
 - < 20 years 10 (7.2)
 - 20-35 years 108 (78.3)
 -  >35 years 20 (14.5)
Employment
 - Housewife 58 (42.0)
 - Employee 24 (17.4)
 - Entrepreneur 8 (5.8)
 - No data 48 (34.8)
Number of Marriage
 - One 65 (47.1)
 - More than one 70 (50.7)
 - Unmarried 1 (0.7)
 - No data 2 (1.5)
Gravida
 - 1 31 (22.5)
 - ≥2 107 (77.5)
Gestational age at delivery
 - Trimester 2 2 (1.4)
 - Trimester 3 136 (98.6)
Fetus
 - Singleton 137 (99.3)
 - Multi fetus 1 (0.7)
History of Ante Natal Care
 - No data 45 (32.6)
 - ANC 1-3 times 26 (18.8)
 - ANC ≥ 4 times 67 (48.6)
Delivery method
 - Vaginal delivery 22 (15.9)
 - Cesarean section 116 (84.1)
Intrapartum complications
 - Premature rupture of membrane 34 (24.7)
 - Preeclampsia 8 (5.8)
 - No complication 96 (69.5)
patients gave birth to their infants, they will 
be followed up in obstetry clinic and pediatric 
clinic. Most of the time they use our service up 
to 6 month and they transferred back to other 
health care near their home. Infant diagnosis 
was a challenge since it was not part of PMTCT 
service covered by government until 2017.
Data was retrieved from medical record, 
HIV registry and laboratory results. Maternal 
demographic status including age, education, 
employment, and number of sexual partner. The 
obstetric status including the parity, gestational 
age at admission, number of fetus, frequency of 
antenatal care, and delivery method. HIV status 
of mother including known HIV status before 
pregnancy, ARV consumption, CD4 level, viral 
load level, and the present of opportunistic 
infection. Status of the baby including birth 
weight, use of ARV prophylaxis, and  infant 
result which was determined by at least 2 PCR 
RNA results on 6-8 weeks of age and on 6 month 
of age.
Collected data was presented as distribution 
and displayed in tables as number and 
percentages.
RESULTS
There was a total of 138 subjects who were 
under Cipto Mangunkusumo Hospital care from 
January 2013 to December 2018. Demographic 
data shows that most women were at 20-35 
years old (n=108, 78.3%). Fifty-eight pregnant 
women work as housewife (42%), 24 subjects 
(17.4%) work as employee and 8 subjects (5.8%) 
work as entrepreneur. Seventy subjects (50.7%) 
were on second or more marriage, 65 subjects 
(47.1%) married one time only, and one pregnant 
woman has no marriage status. Number of sexual 
partners was not available since it was not part 
of data collected on medical record.
On the obstetric status, most subjects have 
a history of multigravida more than 2 (n=107, 
77.5%). They usually came at third trimester 
(n=136, 98.6%), with singleton fetus (n=137, 
99.3%), already have ANC more than 4 times 
(n=67, 48.6%), and delivered by C-section 
(n=116, 84.1%). Detailed data on distribution of 
maternal obstetric status can be seen on Table 1. 
Almost all (93%) diagnosed prenatally 
(40%) and intranatal (83 cases, 53%). did not 
received HIV diagnosis prenatally. Ten subjects 
(7.3%) were diagnosed during delivery which 
were seen as diagnosis missed opportunity. 
However around 51% subjects had already on 
ARV for more than 6 months while the rest were 
less than 6 months. 
There were 10 subjects with opportunistic 
condition. According to HIV-WHO disease stage 
3-4, there was 5 with lung tuberculosis, 3 with 
oral candidiasis, and 1 with CMV infection. 
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On the other hand, there was 1 patient with 
Molluscum Contagiosum which categorized as 
HIV- WHO disease stage 1-2. There were 10 
subjects with co-infection, consisted of 8 with 
hepatitis (B or C) and 2 subjects with condyloma 
acuminate. Unfortunately, data of maternal CD4 
and viral load were mostly (78% and 84%) 
unavailable. Distribution of maternal HIV status 
can be seen on Table 2.
baby with viral load above 40 copies/mL. At 6 
months of age, viral load on all the babies were 
undetected. Distribution of baby status can be 
seen on Table 3 and 4.
Table 2. Distribution of HIV status of the mother (2013 
– 2018) (N=138)
Characteristic of Subjects n (%)
HIV diagnosis
 - Before Pregnancy 83 (60.1)
 - During pregnancy 45 (32.6)
 - At Delivery 10 (7.3)
Mother’s ARV
 - No ARV 32 (23.2)
 - ARV <6 months 26 (18.8)
 - ARV >6 months 70 (50.7)
 - N/A 10 (7.3)
The last CD4 level
 - < 200sel/uL 8 (5.8)
 - 200-500 sel/uL 20 (14.5)
 - ≥ 500sel/Ul 2 (1.5)
 - N/A 108 (78.2)
The last viral load level
 - < 50 copies/mL 14 (10.2)
 - 50-400 copies/mL 2 (1.4)
 - 401-1000 copies/mL 0 (0.0)
 - >1000 copies/mL 6 (4.3)
 - N/A 116 (84.1)
WHO HIV stage
 - Stage 1-2 129 (93.4)
 - Stage 3-4 9 (6.6)
Table 3. Description and outcome of baby (2013-2018) 
(N=138)
Characteristic of Subjects n (%)
Birth weight
 - < 1000 g 1 (0.7)
 - 1000 to <1500 g 3 (2.2)
 - 1500 to <2500 g 24 (17.4)
 - 2500 to <3500 g 100 (72.5)
 - ≥ 3500 g 10 (7.2)
Baby’s ARV
 - No data 3 (2.2)
 - Yes 135 (97.8)
 - No 0 (0.0)
Table 4. Baby’s viral load examination (2016-2018) 
(N=66).
Variables n (%)
Baby’s VL examination at 6 weeks
 - No data 42 (63.6)
 - Undetected 23 (35.0)
 - Detected (> 40 copies/mL) 1 (1.4)
Baby’s VL examination at 6 months
 - No data 49 (74.2)
 - Undetected 17 (25.8)
 - Detected (> 40 copies/mL) 0 (0.0)
Most babies born with birth weight 2500-
3500 gr (n=100; 72.5%) and received ARV 
prophylaxis (n=135; 98%).
There was small number of pregnancy with 
HIV during 2013-2018; it was 1.4% in 2013, 
1.3% in 2014, 1.1% in 2015, 1.6% in 2016, 1.3% 
in 2017, and 1.5% in 2018 among all pregnant 
patients in Cipto Mangunkusumo Hospital. 
Unfortunately we do not have infant data from 
2013-2015. Therefore, we analyzed 66 infants 
result only from 2016-2018. There were 24 
babies with viral load results at 6 weeks and 1 
Bivariate analysis revealed no significant 
correlation between maternal ARV consumption 
and neonatal virology result at 6 weeks (P=0.077) 
and at 6 months (p=0.795). Maternal CD4 level 
was not significantly correlate with neonatal 
virology status at 6 weeks (P=0.784) and 6 
months (p=0.671).
DISCUSSION
This is the first study that try to explain the 
cascade of HIV transmission from mother to 
child who use care from intranatal through post 
natal in Cipto Mangunkusumo Hospital. During 
study time there was 138 pregnant patients with 
HIV, which use obstetry care in RSCM. They 
were mostly at 20-24 years old, which is similar 
to any HIV worldwide epidemy.1,2 According to 
UNAIDS, there was approximately 36.7 million 
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people infected with HIV, among which 26% of 
new infections occured in women aged 15-25 
years old.
Women education plays an important 
risk in HIV infection, according to WHO that 
woman has less access to education and lack of 
employment opportunity have higher probability 
for HIV infection.2 Around 50.8% women who 
live with HIV in USA were also not graduate 
from high school.3 Unfortunately there was 
no data on subjects education in our study. 
The majority of our subjects were housewife 
(41.3%). This is similar with study on 109 
patients with HIV, which 17% were women; 
45% were unemployed.4
History of more than one sexual partner 
(50.73%) reflected in our data in which more 
than half were on their second marriage. This 
finding was similar with data from a research in 
Russia, among 758 HIV cases there were 73.9% 
with multi partners.5 Marital relationships does 
not translate into less risk of HIV infection. 
Yang in Cambodia, shown that HIV transmission 
within marital relationships have increased, this 
was transmission from HIV-positive men to 
their HIV-negative spouses. Plausible factors 
influencing inter-spousal HIV transmission 
were a hierarchical male dominated society, 
husbands’ involvement with sex workers, 
cultural values concerning the ideal Khmer 
woman and unprotected sex between an HIV 
infected husband and his uninfected wife.6
Our study presented a higher distribution 
of multigravidity (77.5%), similar to a larger 
study in Malawi with 87.3% (2426) with >2 
pregnancies. Compared with another study, a 
surveillance study in the United Kingdom and 
Ireland showed 65.7% (n:144 ) multigravidity.7,8 
This numbers were associated with conception 
rates, which were influenced by sexual activity, 
procreational intent, fertility, and access to and 
use of contraception. A higher rate of conception 
rate, likely reflecting on perceived improvement 
in HIV treatment and vertical transmission risk.
In our study, 99.3% of our subjects were 
pregnant with single fetus. This result is 
comparable with other studies. Kreitchmann 
R et al in a cohort study in Latin America and 
the Caribbean shows 96.7% (n=1483) single 
fetus pregnancy.6 From another study, lower 
transmission rates area also seen in twin’s 
deliveries compared with single deliveries, with 
twice as likely not to be infected than single born 
infant (OR = 0.5% CI 0.378-0.85 p=0.007), based 
on study by Nkenfou CN et al.9 It is speculated 
that more care is given in multiple pregnancies. 
This occurs in their study, that more women with 
multiple pregnancy underwent prevention of 
mother-to-child transmission than women with 
single pregnancy (p=0.02).9 However a more 
recent study concludes that twin pregnancies 
had lower risk of HIV transmission, provided 
that the mother is on highly active antiretroviral 
therapy (HAART) or has received effective ARV 
treatment in the antenatal period.10,11
Our study shows sufficient ANC visits 
(48.6%). ANC can be a media to ensure that 
pregnant mothers received ARV to their HIV 
condition, as a prophylaxis to mother-to-
child transmission. Mothers who did not take 
prophylaxis during ANC were three times 
more likely to transmit HIV to their children 
compared to those who took the prophylaxis 
during ANC. (AOR: 3.1; 95% CI: 1.3, 0.9). Lack 
of prophylaxis may increase viral load and its 
chance to transmit HIV to their children. ANC 
visits itself were not statistically significant.12 
Our study shows higher number of ANC visits 
(>4 ANC visits, 48.6%, n: 67), though not 
significantly higher compared to less ANC visits 
number.
A study by UNAIDS in 2013 showed that 
54% pregnant women in low and middle-income 
countries did not had routine HIV tests during 
ANC, which is an important step to prevent 
HIV transmission.13 Therefore, in Indonesia 
itself, there was a low coverage of pregnant 
women living with HIV accessing antiretroviral 
medicines. Even so there is an increase from 9% 
in 2010 to 21% in 2016.2 Which may explain, 
even though the HIV mothers conducts frequent 
ANC visits, it is not a guarantee to receiving 
HIV prophylaxis.
Delivery method in our study were dominated 
by cesarean section (84.1%, n:116), similar to a 
study in a tertiary care in India 91.5% mothers 
delivered by cesarean sections.13 The mothers 
were counseled about the benefits and risks of the 
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delivery types. The majority opted for cesarean 
delivery to prevent perinatal transmission.14 
However, the total number of cesarean delivery 
among pregnant women with HIV in Japan and 
Korea relatively small with 9 pregnant women 
in Japan for 3 years and 15 pregnant women for 
12 years.
In this study, HIV status of patients (53%) was 
unknown before pregnancy. This is because the 
HIV test has not been carried out simultaneously 
for screening before pregnancy in Indonesia. 
Data from UNAIDS obtained in 2016, around 
40% of individuals living with HIV globally 
do not know their HIV status.2 In 2013, 54% 
of pregnant women in low- and middle-income 
countries did not get an HIV test done.15 Costa 
et al.16 reported routine HIV screening during 
pregnancy was effective and recommended for 
preventing universal mother-infant transmission 
(p <0.001). But in reality many hospitals and 
primary health care have not implemented the 
program HIV screening in pregnant women is an 
effort to detect HIV in pregnant women.
As there was only 50.7% patients having 
ARV more than 6 months though almost 93% 
patients was diagnosed HIV before and after 
pregnancy, we assumed that diagnosis of HIV 
was not early in pregnancy or if done early did 
not automatically followed by having ARV. Ten 
patients (7.3%) also was diagnosed at delivery 
that translated as failure of HIV screening 
before pregnancy (as premarital screening) and 
during pregnancy (as 1st trimester screening). 
This could be a failure of a national program 
for 1st trimester screening for HIV infection in 
Indonesia. This could occur also because there 
was a not financial coverage for HIV infection 
screening.17
Our finding shows that ART was given more 
than 6 months before delivery (50%). This is 
similar with previous research at the Haji Adam 
Malik General Hospital Medan in 2012-2016 
based on the duration of antiretroviral (ARV) 
use, the highest was found in the duration of >1 
year as many as 44 people (97.8%) and followed 
by a duration of <6 months as many as 1 person 
(2.2%). Then HIV / AIDS pregnant women with 
duration of 6-12 months antiretroviral use and 
HIV / AIDS pregnant women who have never 
taken antiretroviral drugs each have the same 
number of respondents as many as 0 people 
(0%).18
One consideration is to allow pregnant 
patients with HIV, among others, if the immune 
system is good enough, CD4 above 500.19 In a 
previous study at the Medan Malik Haji General 
Hospital in Medan 2012-2016, it was found that 
HIV / AIDS pregnant women with a CD4 count 
<350 / mm were 22 people (48.9%). In HIV / 
AIDS pregnant women with a CD4 count of 
>350 / mm3 as many as 17 people (37.8%), and 
in medical records that have no data obtained as 
many as 6 people (13.3%).18 Other studies at 
Midwifery Poly Sanglah Hospital Denpasar, July 
2013 - June 2014, there were 25 patients who 
had CD4 > 200 cells / mm3 (59.5%).10 In the 
study in RSCM in 2013-2018, it was found that 
HIV / AIDS pregnant women with a CD4 count 
< 200 cell/uL were 8 people (8%). In HIV/ AIDS 
pregnant women with a CD4 count of 200-500 
cell/uL were 20 people (14%). In HIV/ AIDS 
pregnant women with a CD4 count of >500 
cell/uL were 2 cases (1%) and 108 cases (78%) 
cannot be counted.
Considerations to allow pregnant people 
with HIV include: if the immune system is good 
enough, viral load is minimal / undetectable (less 
than 1000 copies / ml).9 In this study, patients 
with viral load level <50 copies / ml were 
recorded as many as 14 patients (10%), viral load 
level 50-400 copies / ml as many as 2 patients 
(1%), and not counted as many as 116 (84%).
In our study, opportunistic infections 
occurred only in 20 patients (14%). HIV / AIDS 
is characterized as a severe immunosuppressive 
disease that is often associated with opportunistic 
infections.11 Previous research at the Dr. Wahidin 
Sudirohusodo Hospital in Makassar during May 
2011 - April 2012 shows that out of 172 cases 
of HIV-AIDS, 121 people (70%) suffered from 
opportunistic infections.12 The incidence of 
non-opportunistic infections is lower than the 
incidence of opportunistic infections at Cipto 
Mangunkusumo Hospital, Jakarta.
In our study, 72.5% babies were born with 
birth weight 2500-3500 gr. This result is similar 
with the study by Ahmudu.21 in Nigeria, which 
found that 81% babies born from HIV positive 
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mothers have birth weight more than 2500 gr. 
Based on study by European Collaborative 
Study,22 neither birth weight and height was 
associated with HIV infection status in neonates. 
ARV prophylaxis was administered on 135 
babies (97.8%). There was no available data on 
3 babies (2.2%), which could be because the 
babies were premature with neonatal problems 
that prohibited oral intake in the first 72 hour. 
According to our protocol, ARV prophylaxis 
is mandatory to all babies born from mother 
with HIV infection. This protocol is similar to 
WHO recommendation that a short duration 
of antiretroviral prophylaxis (for 4-6 weeks) is 
indicated for infant born to HIV infected women 
receiving ART, to further reduce peripartum and 
postpartum HIV transmission, in addition to 
the protection received from the mother’s ARV 
regimen.2 Regardless of infant feeding choice, 
infant prophylaxis provides added protection 
from early postpartum transmission, particularly 
in situations where women have started ART 
late in pregnancy, have less than optional 
adherence to ART and have not achieved full 
viral suppression. Through this study, we also 
found there was 1 baby with positive viral load 
at 6 weeks age and no baby with positive viral 
load at 6 months age. This success story was 
consistent with WHO recommendation about 
HIV prophylaxis for babies delivered by mother 
with HIV infection.2
Bivariate analysis showed that antiretroviral 
therapy during pregnancy was associated with 
neonatal virology status even though with not 
significant result statistically. This result similar 
with meta-analysis from Cochrane.23 A regimen 
combining triple antiretrovirals is most effective 
for preventing transmission of HIV from mothers 
to babies. Short courses of antiretroviral drugs 
are also effective for reducing mother-to-child 
transmission of HIV and are not associated with 
any safety concerns in the short-term.
CONCLUSION
HIV screening in pregnant women is 
important and should be performed prenatally 
or during early pregnancy, in order to apply 
ARV prevention in mother, safe infant delivery, 
prophylaxis ARV in infant and negative 
transmission results which we showed in this 
study. Our study showed that in those with 
completed data, prevention of transmission 
HIV can be done successfully. Support to 
completeness of PMTCT should be part of 
program covered by government.
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